Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BEN 2293

Next Previous
X
Search
Drug Profile

BEN 2293

Alternative Names: BEN-00002293; BEN-2293

Latest Information Update: 28 Sep 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BenevolentAI
  • Class Anti-inflammatories; Skin disorder therapies; Small molecules
  • Mechanism of Action TrkA receptor antagonists; TrkB receptor antagonists; TrkC receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Atopic dermatitis

Highest Development Phases

  • Suspended Atopic dermatitis

Most Recent Events

  • 25 May 2023 Suspended - Phase-I/II for Atopic dermatitis (In the elderly, In adults) in Poland, Netherlands, Hungary, United Kingdom (Topical)
  • 05 Apr 2023 Efficacy and adverse event data from a phase I/II clinical trials in Atopic dermatitis released by BenevolentAI
  • 16 Mar 2023 BEN 2293 is available for licensing as of 16 March 2023. https://www.benevolent.com/ (BenevolentAI website, March 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top